Hygenia Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.40 M
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 55.18%
- Profit Growth -23.41%
- Ebitda -183.63%
- Net Worth 68.47%
- Total Assets 7.28%
About Hygenia Biotech
Hygenia Biotech Private Limited (HBPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 February 2011 and has a history of 13 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Manish Aggarwal and Gaurav Rana serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232DL2011PTC214109
-
Company No.
214109
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Feb 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Hygenia Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Rana
|
Director | 18-Jan-2020 | Current |
|
Manish Aggarwal
|
Director | 15-Feb-2011 | Current |
Financial Performance of Hygenia Biotech.
Hygenia Biotech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 55.18% increase. The company also saw a substantial fall in profitability, with a 23.41% decrease in profit. The company's net worth Soared by an impressive increase of 68.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hygenia Biotech?
In 2021, Hygenia Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ventis Pharmaceuticals Private LimitedManish Aggarwal is a mutual person
-
Ventis Healthcare Private Limited
Manish Aggarwal is a mutual person
-
Cureia Labs Private Limited
Manish Aggarwal is a mutual person
-
Mascom Opinion Private Limited
Manish Aggarwal is a mutual person
-
Cenofys Healthcare Llp
Gaurav Rana is a mutual person
-
Cerotic Healthcare Private Limited
Gaurav Rana is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hygenia Biotech?
Unlock and access historical data on people associated with Hygenia Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hygenia Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hygenia Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
